Characterization of Differential GPX4 Essentiality Between Intrahepatic and Extrahepatic Cholangiocarcinoma via Leveraging of a Large-Scale Functional Genomic Screen
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262411990 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Ye Rim Lee und 4 weiteren Autor:innen. Beteiligte Einrichtung: AI-Biology & Pharmaceutical Science, Chungnam National University, Daejeon 34134, Republic of Korea. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Phospholipid Hydroperoxide Glutathione Peroxidase, Bile Duct Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, National Research Foundation of Korea (NRF) grant funded by the Korea government, Institute of Information & Communications Technology Planning & Evaluation (IITP) grant funded by the Korea government.
Abstract (Originalsprache)
Ferroptosis has emerged as a promising therapeutic vulnerability of diverse malignancies, yet the regulatory circuits adopted by each in cholangiocarcinoma (CCA) subtypes remain incompletely understood. We integrated the genome-wide CRISPR–Cas9 loss-of-function screens and transcriptomic profiles of the Cancer Dependency Map and then systematically assessed the essentiality of ferroptosis suppressor genes (FSGs) in the intrahepatic (iCCA) and extrahepatic (eCCA) subtypes. Nineteen and 16 essential FSGs were identified in iCCA and eCCA, respectively, among which GPX4 exhibited a significantly higher dependency in iCCA. Pharmacological inhibition of GPX4 with RSL3 markedly reduced cell viability and induced lipid peroxidation in iCCA cell lines, whereas eCCA cell lines displayed pronounced resistance associated with elevated GPX4 expression. A transcriptomic comparison revealed enrichment of WNT signaling in eCCA. Co-treatment with the tankyrase inhibitor XAV-939 and RSL3 enhanced growth inhibition of eCCA cells, indicating that WNT signaling contributed to ferroptosis resistance. These findings indicate that iCCA exhibits a preferential dependency on GPX4, whereas WNT–β-catenin signaling mediates resistance in eCCA. Collectively, the results clarify the molecular basis of subtype-specific ferroptosis vulnerability and offer a rationale for combinatorial therapeutic strategies that integrate GPX4 and WNT pathway inhibition when treating refractory eCCA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- AI-Biology & Pharmaceutical Science, Chungnam National University, Daejeon 34134, Republic of Korea.
- College of Pharmacy, Chungnam National University, Daejeon 34134, Republic of Korea.
ORCID-Profile: Chaeyoung Seo, Md Abdullah, Seung Jin Lee
Förderung
- National Research Foundation of Korea
- National Research Foundation of Korea (NRF) grant funded by the Korea government
- Institute of Information & Communications Technology Planning & Evaluation (IITP) grant funded by the Korea government
Zitieren
APA
Lee, Y. R., Seo, C., Abdullah, M., Baek, S. H., & Lee, S. J. (2025). Characterization of Differential GPX4 Essentiality Between Intrahepatic and Extrahepatic Cholangiocarcinoma via Leveraging of a Large-Scale Functional Genomic Screen. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262411990
Vancouver
Lee YR, Seo C, Abdullah M, Baek SH, Lee SJ. Characterization of Differential GPX4 Essentiality Between Intrahepatic and Extrahepatic Cholangiocarcinoma via Leveraging of a Large-Scale Functional Genomic Screen. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262411990
BibTeX
@article{Lee2025,
author = {Lee, Ye Rim and Seo, Chaeyoung and Abdullah, Md and Baek, Su Hyun and Lee, Seung Jin},
title = {Characterization of Differential GPX4 Essentiality Between Intrahepatic and Extrahepatic Cholangiocarcinoma via Leveraging of a Large-Scale Functional Genomic Screen},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262411990}
}
EUVIMED